These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Transient narcolepsy-cataplexy syndrome after discontinuation of the antidepressant venlafaxine. Nissen C; Feige B; Nofzinger E; Riemann D; Berger M; Voderholzer U J Sleep Res; 2005 Jun; 14(2):207-8. PubMed ID: 15910521 [No Abstract] [Full Text] [Related]
24. Methylphenidate and narcolepsy: new indication. When modafinil fails. Prescrire Int; 2001 Feb; 10(51):7-9. PubMed ID: 11503860 [TBL] [Abstract][Full Text] [Related]
25. [Paranoid psychosis after treatment with the antibiotic ofloxacin]. Hollweg M; Kapfhammer HP Psychiatr Prax; 1996 Sep; 23(5):251. PubMed ID: 8992525 [No Abstract] [Full Text] [Related]
26. Effects of d-amphetamine withdrawal in rats and man. Johnson SW; Freedman R; Sorensen SM Am J Psychiatry; 1983 Jul; 140(7):953-4. PubMed ID: 6859334 [No Abstract] [Full Text] [Related]
27. A case of psychosis and delirium following withdrawal from triazolam. Heritch AJ; Capwell R; Roy-Byrne PP J Clin Psychiatry; 1987 Apr; 48(4):168-9. PubMed ID: 3558332 [TBL] [Abstract][Full Text] [Related]
30. MPH and thrombocytosis. Sood RK; Kirkwood CK; Sood B J Am Acad Child Adolesc Psychiatry; 1994 May; 33(4):592-3. PubMed ID: 8005916 [No Abstract] [Full Text] [Related]
31. Methylphenidate: a review of its neuropharmacological, neuropsychological and adverse clinical effects. Leonard BE; McCartan D; White J; King DJ Hum Psychopharmacol; 2004 Apr; 19(3):151-80. PubMed ID: 15079851 [No Abstract] [Full Text] [Related]
32. Factors influencing the suppressant effects of two stimulant drugs on the growth of hyperactive children. Safer DJ; Allen RP Pediatrics; 1973 Apr; 51(4):660-7. PubMed ID: 4697515 [No Abstract] [Full Text] [Related]
33. Psychiatric morbidity in narcoleptics on chronic high dose methylphenidate therapy. Pawluk LK; Hurwitz TD; Schluter JL; Ullevig C; Mahowald MW J Nerv Ment Dis; 1995 Jan; 183(1):45-8. PubMed ID: 7807070 [No Abstract] [Full Text] [Related]
34. Paranoid psychosis related to mefloquine antimalarial prophylaxis. Fuller SJ; Naraqi S; Gilessi G P N G Med J; 2002; 45(3-4):219-21. PubMed ID: 12968793 [TBL] [Abstract][Full Text] [Related]
35. [Laxative abuse, hypokalemia and sympatomatic psychosis]. Grüneberg F; Kessel M Verh Dtsch Ges Inn Med; 1969; 75():738-40. PubMed ID: 5401622 [No Abstract] [Full Text] [Related]
37. Abusive prescription of psychostimulants: a study of two cases. Pélissier-Alicot AL; Piercecchi-Marti MD; Bartoli C; Kuhlmann E; Coiffait PE; Sanvoisin A; Giocanti D; Léonetti G J Forensic Sci; 2006 Mar; 51(2):407-10. PubMed ID: 16566781 [TBL] [Abstract][Full Text] [Related]
38. REM changes in narcolepsy with selegiline. Reinish LW; MacFarlane JG; Sandor P; Shapiro CM Sleep; 1995 Jun; 18(5):362-7. PubMed ID: 7676170 [TBL] [Abstract][Full Text] [Related]
39. Restless legs syndrome in narcolepsy: a side effect of sodium oxybate? Abril B; Carlander B; Touchon J; Dauvilliers Y Sleep Med; 2007 Mar; 8(2):181-3. PubMed ID: 17275405 [TBL] [Abstract][Full Text] [Related]
40. Hypersensitivity to methylphenidate and dextroamphetamine: a report of two cases. Sverd J; Hurwic MJ; David O; Winsberg BG Pediatrics; 1977 Jan; 59(1):115-7. PubMed ID: 840528 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]